News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA, Barr Pharmaceuticals, Inc. (BRL) To Meet August 8 On Morning-After Pill


8/2/2006 10:18:09 AM

Barr Pharmaceuticals Inc. and the U.S. Food and Drug Administration are scheduled to meet Tuesday to discuss the company's bid to sell its morning-after contraceptive Plan B without a prescription, the agency said on Wednesday.


Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES